Parkinson's Disease Research
Gb Sciences to Begin Dosage Study for Its Novel Parkinson's Disease Formulations at the University of Lethbridge
Gb Sciences, Inc.
PR-M04-22-08Apr 12, 2022
Antibody Therapeutics
Developing New Antibody Therapeutics for COVID-19 and Beyond
Ian Chan
Abpro
PAO-01-22-CL-01Mar 12, 2022
Neurodegenerative Diseases
Uncovering New Drug Targets for Neurological Diseases
Brad Margus
Cerevance
PAO-02-022-CL-10Mar 12, 2022